Gland Pharma Limited (NSE: GLAND)
India
· Delayed Price · Currency is INR
1,774.00
+70.60 (4.14%)
Nov 14, 2024, 3:30 PM IST
Gland Pharma Revenue
Gland Pharma had revenue of 14.06B INR in the quarter ending September 30, 2024, with 2.36% growth. This brings the company's revenue in the last twelve months to 58.90B, up 36.81% year-over-year. In the fiscal year ending March 31, 2024, Gland Pharma had annual revenue of 56.65B with 56.29% growth.
Revenue (ttm)
58.90B
Revenue Growth
+36.81%
P/S Ratio
4.96
Revenue / Employee
13.97M
Employees
4,217
Market Cap
292.27B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionGland Pharma News
- 5 days ago - Gland Pharma stock jumps 10% this week after Q2 results - Business Upturn
- 9 days ago - Gland Pharma shares surge over 12% – Know More - Business Upturn
- 9 days ago - Gland Pharma shares jump 6% on Q2 FY25 results - Business Upturn
- 9 days ago - Gland Pharma share price: Goldman Sachs maintains sell call on Gland Pharma with target price of Rs 1,450, sees 10% downside - Business Upturn
- 10 days ago - Gland Pharma Q2 FY25 Results: Revenue grows 2.4% YoY to Rs 1,405.83 crore; net profit falls 15.7% to Rs 163.53 crore - Business Upturn
- 24 days ago - Pharma stocks today: Gland Pharma rises 1.53%, Aurobindo Pharma up 1.38%, while Natco Pharma falls 1.40%, and Laurus Labs down 1.41% - Business Upturn
- 4 weeks ago - Pharma Stocks Update: Check out how Cipla, Lupin, Abbott India, Divi’s Lab, Zydus Life, Dr Reddy’s Lab are performing today - Business Upturn
- 6 weeks ago - Stocks Update: Phoenix Mills drops 4.77%, Gland Pharma down 3.73%, and United Spirits loses 3.61% in today’s session - Business Upturn